Temporal Regulation of Agonist Efficacy at 5-Hydroxytryptamine (5-HT)1A and 5-HT1BReceptors
Open Access
- 1 January 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 304 (1) , 200-205
- https://doi.org/10.1124/jpet.102.042564
Abstract
Coactivation of purinergic (P2Y) receptors reduces agonist efficacy at serotonin1B (5-HT1B), but not 5-HT1A receptors. Herein, we report that pretreatment for 5 min with the P2Y receptor agonist ATP reduced agonist responsiveness at the 5-HT1A, but not at the 5-HT1B, receptor. The effect of ATP pretreatment on the 5-HT1A receptor response rapidly reversed within a 10 min time frame between P2Y receptor and 5-HT1Areceptor activation. ATP pretreatment effects on 5-HT1Aagonist responsiveness were blocked by the protein kinase inhibitors staurosporine and bisindolylmaleimide, suggesting that the ATP-mediated temporal regulation involves activation of protein kinase C (PKC). Moreover, the temporal effect of ATP was blocked by incubation with 1% ethanol, suggesting that consequences of phospholipase D (PLD) activation play a role. ATP pretreatment blocked the inhibitory effect produced by 5-HT2C receptor activation on the 5-HT1A, but not the 5-HT1B, receptor response, suggesting that the 5-HT1A receptor itself was the target for PLD/PKC action. Finally, ethanol did not block the reduction in responsiveness of the 5-HT1A receptor system produced by activation of PKC with phorbol ester treatment, suggesting that PKC activation lies downstream of PLD. Taken together, these data suggest that activation of P2Y receptors can reduce responsiveness of the 5-HT1A receptor system via a PLD/PKC-dependent mechanism that is highly dependent upon the temporal pattern of receptor activation. Moreover, this work underscores the importance of time as a variable in receptor signaling cross talk and serves to further illustrate differences between the 5-HT1A and 5-HT1B receptor systems.Keywords
This publication has 28 references indexed in Scilit:
- Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic DisordersNeuropsychopharmacology, 1999
- Phospholipase DBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1998
- Interactions between Effectors Linked to Serotonin ReceptorsAnnals of the New York Academy of Sciences, 1998
- Phospholipase D: enzymology, mechanisms of regulation, and functionPhysiological Reviews, 1997
- The 5-HT1A receptor: Signaling, desensitization, and gene transcriptionNeuropsychopharmacology, 1996
- The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channelsNeuropeptides, 1994
- Increases in intracellular calcium via activation of an endogenous P2‐purinoceptor in cultured CHO‐K1 cellsBritish Journal of Pharmacology, 1993
- Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: A homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificityBiochemical and Biophysical Research Communications, 1992
- 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigraEuropean Journal of Pharmacology, 1988
- Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonistsEuropean Journal of Pharmacology, 1985